Back
  1. Home
  2. Profile of Lisette Trzpiot (ULiège)
Profil

Trzpiot Lisette

See author's contact details
Main Referenced Co-authors
Baiwir, Dominique  (9)
Eppe, Gauthier  (9)
Fleron, Maximilien  (9)
Huynh-Thu, Vân Anh  (9)
Louis, Edouard  (9)
Mazzucchelli, Gabriel  (9)
Main Referenced Keywords
Crohn's disease (3); blood protein (2); colon (2); ileum (2); ulcer (2);
Main Referenced Disciplines
Gastroenterology & hepatology (9)

Publications (total 9)

The most downloaded
611 downloads
Pierre, N., Huynh-Thu, V. A., Baiwir, D., Mazzucchelli, G., Fleron, M., Trzpiot, L., Eppe, G., De Pauw, E., Laharie, D., Satsangi, J., Bossuyt, P., Vuitton, L., Vieujean, S., Colombel, J.-F., Meuwis, M.-A., Louis, E., & GETAID and the SPARE-Biocycle research group. (2024). External validation of serum biomarkers predicting short-term and mid/long-term relapse in patients with Crohn's disease stopping infliximab. Gut, 2024-332648. doi:10.1136/gutjnl-2024-332648 https://hdl.handle.net/2268/322682

The most cited

9 citations (Scopus®)

Pierre, N., Huynh-Thu, V. A., Baiwir, D., Mazzucchelli, G., Fleron, M., Trzpiot, L., Eppe, G., De Pauw, E., Laharie, D., Satsangi, J., Bossuyt, P., Vuitton, L., Vieujean, S., Colombel, J.-F., Meuwis, M.-A., Louis, E., & GETAID and the SPARE-Biocycle research group. (2024). External validation of serum biomarkers predicting short-term and mid/long-term relapse in patients with Crohn's disease stopping infliximab. Gut, 2024-332648. doi:10.1136/gutjnl-2024-332648 https://hdl.handle.net/2268/322682

Contact ORBi